Synergistic application of zinc and vitamin C to support memory, attention and the reduction of the risk of the neurological diseases

Close metadata

Recommended articles:

Associations of serum neuromarkers with clinical features of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):145-152

Prevalence of cognitive impairment in older adults in the Russian Federation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):5-11

Cognitive impairment in cerebrovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):12-16

Comparative characteristics of neuropsychological and neurometabolic changes in patients with Alzheimer’s disease and vascular cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):17-24

EEG changes in patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):72-76

Drug-induced cognitive impairment and dementia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):77-85

Cognitive impairment in multiple system atrophy — exclusion criteria or an integral part of the clinical picture?. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):86-91

Meta-analysis of randomized controlled trials of the effectiveness of Prospekta in the treatment of vascular cognitive impairment of varying severity. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):62-69

Experience of using the combined drug Mioreol in patients with Alzheimer’s disease and mixed dementia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):34-43

Objective functional monitoring of retinoprotective treatment in diabetic retinopathy. Russian Annals of Ophthalmology. 2024;(1):45-56

Zinc and vitamin C supplementation of the body is important for CNS functioning. Zinc ions are involved in the neurotransmission (signal transmission from acetylcholine, catecholamine, serotonin, prostaglandin receptors) and in ubiquitin-related protein degradation. Zinc deficits are associated with Alzheimer’s disease and depression. Zinc supplementation (10—30 mg daily) improves neurologic recovery rate in patients with stroke and brain injury, has a positive impact on memory and reduces hyperactivity in children. Vitamin C, a zinc synergist, maintains antioxidant resources of the brain, synaptic activity and detoxification. Vitamin C in dose 130—500 mg daily should be used to prevent dementia and neurodegenerative pathology.

Keywords:

zinc

vitamin C

dementia

neurodegeneration

hyperactivity

Authors:

Gromova O.A.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna;
kafedra farmakologii i klinicheskoĭ farmakologii Ivanovskoĭ gosudarstvennoĭ meditsinskoĭ akademii

ORCID: 0000-0002-7663-710X

Torshin I.Iu.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna

Pronin A.V.

Ivanovo State Medical Academy, Ivanovo

Kilchevsky M.A.

Ivanovo State Medical Academy of the RF Ministry of Health, Ivanovo, Russia

List of references:

Mackenzie GG, Salvador GA, Romero C, Keen CL, Oteiza PI. A deficit in zinc availability can cause alterations in tubulin thiol redox status in cultured neurons and in the developing fetal rat brain. Free Radic Biol Med. 2011;51(2):480-489. https://doi.org/10.1016/j.freeradbiomed.2011.04.028
Torshin IYu, Gromova O.A. Jekspertnyj analiz dannyh v farmakologii. M.: MNCMNO; 2012. (In Russ.).
Rebrov VG, Gromova OA. Vitaminy, makro- i mikrojelementy. M.: GeotarMed; 2008. (In Russ.).
Acuña AI, Esparza M, Kramm C, Beltrán FA, Parra AV, Cepeda C, Toro CA, Vidal RL, Hetz C, Concha II et al. A failure in energy metabolism and antioxidant uptake precede symptoms of huntington’s disease in mice. Nat Commun. 2013;4:2917-2919. https://doi.org/10.1038/ncomms3917
Torshin IYu. Sensing the change from molecular genetics to personalized medicine. Nova Biomedical Books, NY, USA, 2009, In «Bioinformatics in the Post-Genomic Era» series. ISBN 1-60692-217-0
Kulathu Y, Akutsu M, Bremm A, Hofmann K, Komander D. Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain. Nat Struct Mol Biol. 2009;16(12):1328-1330. https://doi.org/10.1038/nsmb.1731
Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell. 2000;5(4):649-658. https://doi.org/10.1016/s1097-2765(00)80244-0
Lopes da Silva S, Vellas B, Elemans S, Luchsinger J, Kamphuis P, Yaffe K, Sijben J, Groenendijk M, Stijnen T. Plasma nutrient status of patients with Alzheimer’s disease: Systematic review and meta-analysis. Alzheimers Dement. 2014;10(4):485-502. https://doi.org/10.1016/j.jalz.2013.05.1771
Swardfager W, Herrmann N, Mazereeuw G, Goldberger K, Harimoto T, Lanctôt KL. Zinc in depression: a meta-analysis. Biol Psychiatry. 2013;74(12):872-878. https://doi.org/10.1016/j.biopsych.2013.05.008
Aquilani R, Baiardi P, Scocchi M, Iadarola P, Verri M, Sessarego P, Boschi F, Pasini E, Pastoris O, Viglio S. Normalization of zinc intake enhances neurological retrieval of patients suffering from ischemic strokes. Nutr Neurosci. 2009;12(5):219-225. https://doi.org/10.1179/147683009X423445
Young B, Ott L, Kasarskis E, Rapp R, Moles K, Dempsey RJ, Tibbs PA, Kryscio R, McClain C. Zinc supplementation is associated with improved neurologic recovery rate and visceral protein levels of patients with severe closed head injury. J Neurotrauma. 1996;13(1):25-34. https://doi.org/ 10.1089/neu.1996.13.25
Mathur NB, Agarwal DK. Zinc Supplementation in Preterm Neonates and Neurological Development, A Randomized Controlled Trial. Indian Pediatr. 2015;52(11):951-955. https://doi.org/ 10.1007/s13312-015-0751-6
Colombo J, Zavaleta N, Kannass KN, Lazarte F, Albornoz C, Kapa LL, Caulfield LE. Zinc supplementation sustained normative neurodevelopment in a randomized, controlled trial of Peruvian infants aged 6—18 months. J Nutr. 2014;144(8):1298-1305. https://doi.org/10.3945/jn.113.189365
Zamora J, Velásquez A, Troncoso L, Barra P, Guajardo K, Castillo-Duran C. Zinc in the therapy of the attention-deficit/hyperactivity disorder in children. A preliminar randomized controlled trial. Arch Latinoam Nutr. 2011;61(3):242-246. https://doi.org/ 10.1186/isrctn03732556
Himmelreich U, Drew KN, Serianni AS, Kuchel PW. 13C NMR studies of vitamin C transport and its redox cycling in human erythrocytes. Biochemistry. 1998;37:7578-7588. https://doi.org/10.1021/bi970765s
Ishikawa T, Casini AF, Nishikimi M. Molecular cloning and functional expression of rat liver glutathione-dependent dehydroascorbate reductase. J Biol Chem. 1998;273:28708-28712. https://doi.org/10.1074/jbc.273.44.28708
Castro MA, Beltrán FA, Brauchi S, Concha II. A metabolic switch in brain: Glucose and lactate metabolism modulation by ascorbic acid. J Neurochem. 2009;110:423-440. https://doi.org/10.1111/j.1471-4159.2009.06151.x
Peterkofsky B. Ascorbate requirement for hydroxylation and secretion of procollagen: Relationship to inhibition of collagen synthesis in scurvy. Am J Clin Nutr. 1991;54:1135-1140. https://doi.org/10.1016/s0174-173x(87)80045-6
Padh H. Cellular functions of ascorbic acid. Biochem Cell Biol. 1990;68:1166-1173. https://doi.org/10.1139/o90-173
Levine M, Wang Y, Rumsey SC. Analysis of ascorbic acid and dehydroascorbic acid in biological samples. Methods Enzymol. 1999;299:65-76. https://doi.org/10.1002/0471140856.tx0706s12
Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1996;93:1107-1113. https://doi.org/10.1161/01.cir.93.6.1107
Naseer MI, Ullah N, Ullah I, Koh PO, Lee HY, Park MS, Kim MO. Vitamin C protects against ethanol and PTZ-induced apoptotic neurodegeneration in prenatal rat hippocampal neurons. Synapse. 2011;65:562-571. https://doi.org/10.1002/syn.20875
Santos IM, Tome Ada R, Saldanha GB, Ferreira PM, Militao GC, Freitas RM. Oxidative stress in the hippocampus during experimental seizures can be ameliorated with the antioxidant ascorbic acid. Oxid Med Cell Longev. 2009;2:214-221. https://doi.org/10.4161/oxim.2.4.8876
Qiu S, Li L, Weeber EJ, May JM. Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity. J Neurosci Res. 2007;85:1046-1056. https://doi.org/10.1002/jnr.21204
Ghasemzadeh B, Cammack J, Adams RN. Dynamic changes in extracellular fluid ascorbic acid monitored by in vivo electrochemistry. Brain Res. 1991;547:162-166. https://doi.org/10.1016/0006-8993(91)90587-l
Lee L, Kang SA, Lee HO, Lee BH, Park JS, Kim JH, Jung IK, Park YJ, Lee JE. Relationships between dietary intake and cognitive function level in Korean elderly people. Public Health. 2001;115:133-138. https://doi.org/ 10.1016/s0033-3506(01)00432-2
Ortega RM, Requejo AM, Andres P, Lopez-Sobaler AM, Quintas ME, Redondo MR, Navia B, Rivas T. Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr. 1997;66:803-809. https://doi.org/10.1016/s0033-3506(01)00432-2
Polidori MC, Pratico D, Mangialasche F, Mariani E, Aust O, Anlasik T, Mang N, Pientka L, Stahl W, Sies H, Mecocci P, Nelles G. High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects. Journal of Alzheimer’s disease. 2009;17:921-927. https://doi.org/10.3233/jad-2009-1114
McNeill G, Jia X, Whalley LJ, Fox HC, Corley J, Gow AJ, Brett CE, Starr JM, Deary IJ Antioxidant and B vitamin intake in relation to cognitive function in later life in the Lothian birth cohort 1936. Eur J Clin Nutr. 2011;65(5):619-626. https://doi.org/10.1038/ejcn.2011.2
Goodwin JS, Goodwin JM, Garry PJ Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA. 1983;249(21):2917-2921. https://doi.org/ 10.1001/jama.1983.03330450047024
Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ. 1996;312:608-611. https://doi.org/ 10.1136/bmj.312.7031.608
Perrig WJ, Perrig P, Stahelin HB. The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc. 1997;45:718-724. https://doi.org/10.1111/j.1532-5415.1997.tb01476.x
Wengreen HJ, Munger RG, Corcoran CD, Zandi P, Hayden KM, Fotuhi M, Skoog I, Norton MC, Tschanz J, Breitner JC, Welsh-Bohmer KA. Antioxidant intake and cognitive function of elderly men and women: the Cache County Study. J Nutr Health Aging. 2007;11:230-237. https://doi.org/ 10.1016/s0197-4580(04)81561-6
O’Neill RD, Fillenz M, Sundstrom L, Rawlins JN. Voltammetrically monitored brain ascorbate as an index of excitatory amino acid release in the unrestrained rat. Neurosci Lett. 1984;52:227-233. https://doi.org/10.1016/0304-3940(84)90166-6
Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging. 2003;24:915-919. https://doi.org/10.1016/s0197-4580(03)00031-9
Fitzgerald KC, O’Reilly EJ, Fondell E, Falcone GJ, McCullough ML, Park Y, Kolonel LN, Ascherio A. Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: Pooled results from 5 cohort studies. Ann Neurol. 2013;73:236-245. https://doi.org/10.1002/ana.23820
Masaki KH, Losonczy KG, Izmirlian G, Foley DJ, Ross GW, Petrovitch H, Havlik R, White LR. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology. 2000;54:1265-1272. https://doi.org/ 10.1212/wnl.54.6.1265
Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Holman A, Witteman JCM, Breteler MMB. Dietary intake of antioxidants and risk of Alzheimer disease. J Am Med Assoc. 2002;287(24):3223-3229. https://doi.org/10.1001/jama.287.24.3223
Neymotin A, Petri S, Calingasan NY, Wille E, Schafer P, Stewart C, Hensley K, Beal MF, Kiaei M. Lenalidomide (revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis. Exp Neurol. 2009;220:191-197. https://doi.org/10.1016/j.expneurol.2009.08.028
Okamoto K, Kihira T, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, Sakamoto N, Inaba Y, Nagai M. Fruit and Vegetable Intake and Risk of Amyotrophic Lateral Sclerosis in Japan. Neuroepidemiology. 2009;32(4):251-256. Epub 2009 Feb 11. https://doi.org/10.1159/000201563
Rebec GV, Pierce RC. A vitamin as neuromodulator: Ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog Neurobiol. 1994;43:537-565. https://doi.org/10.1016/0301-0082(94)90052-3
Dorner JL, Miller BR, Klein EL, Murphy-Nakhnikian A, Andrews RL, Barton SJ, Rebec GV. Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of huntington’s disease. Brain Res. 2009;1290:111-120. https://doi.org/10.1016/j.brainres.2009.07.019
Ide K, Yamada H, Umegaki K, Yokochi T, Harada K. Lymphocyte vitamin C levels as potential biomarker for progression of Parkinson’s disease. Nutrition. Mizuno K, Kawakami N, Hagiwara Y, Matsumoto M, Yoshida H, Kim K, Shiosaki E. 2015;31(2):406-408. https://doi.org/10.1016/j.nut.2014.08.001
Nagayama H, Hamamoto M, Ueda M, Nito C, Yamaguchi H, Katayama Y. The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease. Clin Neuropharmacol. 2004;27:270-273. https://doi.org/10.1097/01.wnf.0000150865.21759.bc

Close metadata